For diabetes and related illnesses, recent breakthrough GLP-1’s (Ozempic, Wegovy, Mounjaro…) should be deployed and subsidized as rapidly and broadly as possible.
Deploy and subsidize GLP-1 treatments for diabetes and related illnesses as rapidly and broadly as possible.
Occurrences
Evidence
No stored evidence yet.
Assessments
No assessments yet.